Navigation Links
GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
Date:7/8/2011

drome occurred within 6 weeks of receipt of a prior tetanus toxoid-containing vaccine
  • Progressive or unstable neurologic conditions are reasons to defer vaccination with a pertussis-containing vaccine, including BOOSTRIX
  • Persons who experienced an Arthus-type hypersensitivity reaction following a prior dose of tetanus toxoid-containing vaccine should not receive BOOSTRIX unless 10 years have elapsed since the last dose of a tetanus toxoid-containing vaccine
  • BOOSTRIX may not protect 100% of individuals receiving the vaccine

  • Boostrix is a registered trademark of GlaxoSmithKline Pharmaceuticals (NYSE: GSK).

    GlaxoSmithKline Biologicals

    GlaxoSmithKline Biologicals (GSK Biologicals), GlaxoSmithKline's vaccines business, is one of the world's leading vaccine companies and a leader in innovation. The company is active in vaccine research, development and production with over 30 vaccines approved for marketing and 20 more in development - both in the prophylactic and therapeutic fields. Headquartered in Belgium, GSK Biologicals has 14 manufacturing sites strategically positioned around the globe. In 2010, GSK Biologicals distributed 1.43 billion doses of vaccines to 179 countries in both the developed and the developing world.

    Through its accomplished and dedicated workforce, GSK Biologicals applies its expertise to the discovery of innovative vaccines that contribute to the health and well-being of people of all generations around the world.

    GlaxoSmithKline

    GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information, please visit www.gsk.com.

    Cautionary statement regarding forward-looking statements

    Under the safe harbor provisions
    '/>"/>

    SOURCE Synaptic Digital; GlaxoSmithKline
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
    2. GlaxoSmithKline Confirms allis Safety Profile
    3. Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
    4. GlaxoSmithKline Wins Environmental Stewardship Award
    5. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
    6. GlaxoSmithKline Applauds North Carolinas Child Advocates
    7. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
    8. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
    9. GlaxoSmithKline CEO Interviewed On Half-Year and Q2 Results
    10. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
    11. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/19/2014)... /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick J. ... an innovative diagnostic procedure for the detection of colorectal ... Disease (SPEC) conference in Krakow, Poland ... of in vitro Diagnostics for Detection of Colorectal Cancer ... conference poster session on Tuesday, August 19, 2014 from ...
    (Date:8/19/2014)...  As power morcellator lawsuits continue to mount ... notes that women in need of fibroid removal ... options that do not involve the use of ... report published by The Wall Street Journal on ... mini-laparotomy and vaginal hysterectomy. Non-surgical options for shrinking ...
    (Date:8/19/2014)... 2014 Research and Markets has announced ... Global Strategic Business Report" report to their offering. ... Growth Hormone Drugs in US$ Million by the following Brands: ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , and Rest ...
    Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Human Growth Hormone Drugs - Strategic Business Report 2014 2
    ... Sept. 1, 2011 Kimberly-Clark Health Care (KCHC) ... price increase on synthetic exam gloves due to ... materials, particularly butadiene and acrylonitrile.   ... raw materials along with inflationary pressures have been ...
    ... 1, 2011 Today, Osseon® Therapeutics, Inc. launched ... newest in Osseon,s suite of minimally invasive products ... (Photo:   http://photos.prnewswire.com/prnh/20110901/SF61461 ) The ... entire vertebral body. The Osseoplasty™ procedure offers unparalleled ...
    Cached Medicine Technology:Osseon® Announces Commercial Release of Osseoflex®SN (Steerable Needle) 2
    (Date:8/19/2014)... (PRWEB) August 19, 2014 Grande ... named the winner of the 2014 Independent Cosmetics ... home the first place position in “Product Innovation; ... specially-formatted eyeliner, which also includes a lash enhancement ... color, plus lash-boosting technology. , This ...
    (Date:8/19/2014)... 2014 In honor of National Dog Day on ... old furry friend by offering tips on caring for aging dogs. ... more. Because of this, dog owners need to realize the dog’s ... age, their needs change. They will not want to spend as ... used to. Because of this, pet owners should consider altering the ...
    (Date:8/19/2014)... Following the completion of a $16 million rooms renovation in ... to debut the highly anticipated final phase of its $20 ... all public spaces to match the fresh look and feel ... experience at 1823 Kitchen and Bar and an innovative tech ... 1823 Kitchen and Bar, Grand Hyatt Tampa Bay has added ...
    (Date:8/19/2014)... admitted to U.S. hospitals cannot smoke during their stay and ... few are able to stay smoke-free after returning home. ... JAMA describes a program that increased the proportion ... more than 70 percent. The system used interactive voice ... and stop-smoking medication for three months after smokers left the ...
    (Date:8/19/2014)... Philadelphia, PA, August 19, 2014 Warfarin, the ... competition from new options in the anticoagulant drug ... study documents the rapid adoption of these novel ... NOACs accounted for 62% of all new anticoagulant ... drug costs. Findings are published in The ...
    Breaking Medicine News(10 mins):Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 2Health News:GrandeLINER™ Wins Independent Cosmetics Manufacturers & Distributors Award 3Health News:The Puppy Store Helps Pet Owners Care for Aging Dogs 2Health News:Grand Hyatt Tampa Bay Hotel Unveils the Finishing Touches of Its $20 Million Makeover 2Health News:Extended support helps patients stay smoke-free after hospital discharge 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 3
    ... begun work into improving the lives of thousands of Cystic ... US-Ireland Research and Development Partnership grant. , The grant ... in the USA with funding for the Queen,s component provided ... Public Health Agency), Northern Ireland and the Medical Research Council. ...
    ... , THURSDAY, Feb. 3 (HealthDay News) -- A special ... disorder (ADHD) in young children, a new study suggests. ... 8 were placed on a diet containing no processed ... percent of them. And, when suspected trouble foods were ...
    ... bone marrow to become embryonic-like stem cells, a team ... the onset of the blood cancer leukemia in the ... blood cells obtained from a patient with leukemia," says ... directed a study aimed at generating all-purpose stem cells ...
    ... -- A single dose of the H1N1 swine flu vaccine ... study found. In order to assess the effectiveness of ... -- Canadian researchers looked at 552 patients with flu-like illness ... Dec. 5, 2009. Pandemic H1N1 was detected in 209 ...
    ... News) -- If you tend to overindulge in food and ... things you can do to ease the ill effects you ... Dr. Cynthia Yoshida offers the following suggestions: Stay ... Caffeine-free, non-carbonated drinks, such as water, can help lessen the ...
    ... (HealthDay News) -- The average starting salary for a female ... a huge increase from the $3,600 gap in 1999, finds ... difference isn,t known because it isn,t explained by gender differences ... researchers said. The study authors analyzed survey data from ...
    Cached Medicine News:Health News:$2.8 million grant boosts cystic fibrosis research at Queen's 2Health News:Restrictive Diet May Reduce ADHD Symptoms 2Health News:Restrictive Diet May Reduce ADHD Symptoms 3Health News:Restrictive Diet May Reduce ADHD Symptoms 4Health News:New induced stem cells may unmask cancer at earliest stage 2Health News:Gender Gap in Starting Doctor Pay Grows 2
    96-Well PCR Plate Sealing Mat...
    Easy to pierce, remove using foil stripper...
    Inquire...
    ... Heat Sealing Foil and Heat Sealing Film each ... allow safe and easy sample storage. In automated ... with standard pipette tips. The Heat Sealing Film ... in the plates. Heat Sealing Foil is removed ...
    Medicine Products: